Jazz Pharmaceuticals PLC (JAZZ.OQ)
Get access to over 18 million research reports from over 1,700 sources.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
- private equity
- third-party document and information retrieval
- and much, much more…
|53||2009||Chairman of the Board, Chief Executive Officer|
|54||2018||President, Chief Operating Officer|
|47||2015||Chief Financial Officer, Executive Vice President|
|51||2012||Executive Vice President, General Counsel|
|53||2013||Senior Vice President - Finance, Principal Accounting Officer|
- BRIEF-Jazz Announces FDA Acceptance Of NDA For Solriamfetol For Excessive Sleepiness Associated With Narcolepsy Or Obstructive Sleep Apnea
- BRIEF-Jazz Pharmaceuticals Q4 GAAP Earnings Per Share $3.79
- BRIEF-Jazz Pharmaceuticals Enrolls First Patient In Clinical Trial of Defibrotide
- BRIEF-Jazz Pharma Submits New Drug Application For Solriamfetol (JZP-110)
- UPDATE 2-United Therapeutics to pay $210 mln to resolve U.S. kickback probe